Asthma and allergy

Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β₂-agonist therapy in patients with asthma: REACH study design
Akio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, Kazuya Sumi, Toshiaki Mikami, Norihiko Kondo

ERJ Open Research Mar 2023, 9 (2) 00452-2022; DOI: 10.1183/23120541.00452-2022
Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
Laurits Frøssing, Ditte K. Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S. Erjefält, Uffe Bodtger, Celeste Porsbjerg

ERJ Open Research Mar 2023, 9 (2) 00483-2022; DOI: 10.1183/23120541.00483-2022
The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma
Elisa Franceschi, Nora Drick, Jan Fuge, Pierachille Santus, Bettina Fischer, Moritz Kayser, Tobias Welte, Hendrik Suhling

ERJ Open Research Mar 2023, 9 (2) 00341-2022; DOI: 10.1183/23120541.00341-2022
NICE asthma guidelines: time to re-evaluate the diagnostic value of exercise challenge testing?
Andrew J. Simpson, Oliver J. Price

ERJ Open Research Mar 2023, 9 (2) 00447-2022; DOI: 10.1183/23120541.00447-2022
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
Lucia De Prado Gomez, Ian Pavord, William Busse, Christopher E. Brightling, Michael E. Wechsler, Klaus F. Rabe, Mei Zhang, Jun Xing, Juby A. Jacob-Nara, Paul J. Rowe

ERJ Open Research Mar 2023, 9 (2) 00417-2022; DOI: 10.1183/23120541.00417-2022
An inverse relationship between asthma prevalence and medication dispensation trend: a 12-year spatial analysis of electronic health record data in Alberta, Canada
Subhabrata Moitra, Andrew Fong, Mohit Bhutani

ERJ Open Research Mar 2023, 9 (2) 00489-2022; DOI: 10.1183/23120541.00489-2022
It is time to end our love affair with short-acting β₂-agonists in asthma? Yes
Luis J. Nannini

ERJ Open Research Jan 2023, 9 (1) 00555-2022; DOI: 10.1183/23120541.00555-2022
Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis
Gilles Louis, Florence Schleich, Michèle Guillaume, Delphine Kirkove, Halehsadat Nekoee Zahrei, Anne-Françoise Donneau, Monique Henket, Virginie Paulus, Françoise Guissard, Renaud Louis, Benoit Pétré

ERJ Open Research Jan 2023, 9 (1) 00451-2022; DOI: 10.1183/23120541.00451-2022
Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
Nastaran Mues, Richard J. Martin, Rafeul Alam, Niccolette Schaunaman, Kris Genelyn Dimasuay, Christena Kolakowski, Clyde J. Wright, Lijun Zheng, Hong Wei Chu

ERJ Open Research Jan 2023, 9 (1) 00474-2022; DOI: 10.1183/23120541.00474-2022
Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials
Eva Topole, Sonia Biondaro, Isabella Montagna, Sandrine Corre, Massimo Corradi, Sanja Stanojevic, Brian Graham, Nilakash Das, Kevin Ray, Marko Topalovic

ERJ Open Research Jan 2023, 9 (1) 00292-2022; DOI: 10.1183/23120541.00292-2022

Main menu

User menu

Search

Asthma and allergy

Pages

Contact us